India | Worsening health conditions crystalise downside risks
The rapidly swelling second wave has taken a big toll on the country’s health infrastructure. The health system has collapsed in the worst hit states, with even the national capital, Delhi, facing acute shortage of oxygen and Covid-19 hospital beds. While the official mortality rate has edged lower, it masks a rapidly rising death count. Deaths are now doubling every ten days (as opposed to an average of 29 days in the first wave) and even this figure is likely buttressed by delayed or under-reporting of deaths.
What you will learn from this report:
- India’s escalating health burden, faltering vaccination rate, and lack of a convincing government strategy to contain the pandemic have prompted us to downgrade our 2021 GDP growth forecast to 10.2% from 11.8% previously.
- GDP is expected to contract sequentially in Q2 and average 1.47% q/q sa in 2021. This is a notable downgrade from our pre-second wave average growth forecast of 1.64%, but represents a modest uptick from 1.44% in 2020.
- Notwithstanding the likelihood of further mobility restrictions, we expect India’s targeted lockdown approach, less stringent restrictions, and resilient consumer and business behaviour to mitigate the economic impact of the second wave.
Tags:
Related Services

Post
Trump’s tariffs on Canada would raise regional commodity prices
A blanket 25% tariff on Canadian imports to the US could have a significant impact on commodity prices, squeeze profit margins of Canadian exporters and raise prices for US end-users.
Find Out More
Post
Chinese policy is unlikely to shift due to announced tariffs
US President Donald Trump's announcement of an additional 10% tariff on imports from China was in line with our baseline expectation. But the immediacy of implementation, the blanket style of tariffs, and the inclusion of stronger language around retaliation in policy documents still add significant uncertainty to our forecasts.
Find Out More